What's New

Last Posted: Jun 27, 2024

• Hereditary Cancer Clinics Improve Adherence to NCCN Germline Testing Guidelines for Pancreatic Cancer.
  Claudia Rosso et al. J Natl Compr Canc Netw 2024 1-7
• Noninvasive prediction of lymph node metastasis in pancreatic cancer using an ultrasound-based clinicoradiomics machine learning model.
  Dong-Yue Wen et al. Biomed Eng Online 2024 23(1) 56
• The role of germline BRCA1 & BRCA2 mutations in familial pancreatic cancer: A systematic review and meta-analysis.
  Edward Kurnia Setiawan Limijadi et al. PLoS One 2024 19(5) e0299276
• Review of the cost-effectiveness of surveillance for hereditary pancreatic cancer.
  Louise Wang et al. Fam Cancer 2024
• The Spanish Familial Pancreatic Cancer Registry (PANGENFAM): a decade follow-up of individuals at high-risk for pancreatic cancer.
  Julie Earl et al. Fam Cancer 2024
• Expanding access to genetic testing for pancreatic cancer.
  Nicolette Juliana Rodriguez et al. Fam Cancer 2024
• Development and Application of a Novel Machine Learning Model Predicting Pancreatic Cancer-Specific Mortality.
  Yongji Sun et al. Cureus 2024 16(3) e57161
• Impact of Family History and Germline Genetic Risk Single Nucleotide Polymorphisms on Long-Term Outcomes of Favorable-Risk Prostate Cancer.
  Florian Rumpf et al. J Urol 2024 101097JU0000000000003927
• Olaparib not cost-effective as maintenance therapy for platinum-sensitive, BRCA1/2 germline-mutated metastatic pancreatic cancer.
  Tarun Mehra et al. PLoS One 2024 19(4) e0301271
• Population-based BRCA germline mutation screening in the Han Chinese identifies individuals at risk of BRCA mutation-related cancer: experience from a clinical diagnostic center from greater Shanghai area.
  Zhiyuan Wu et al. BMC Cancer 2024 24(1) 411
• Lynch Syndrome Ups Risk for Colorectal, Other Cancers
  E Herlache, Cancer Care, March 2024
• The Italian registry of families at risk for pancreatic cancer (IRFARPC): implementation and evolution of a national program for pancreatic cancer surveillance in high-risk individuals.
  Livia Archibugi et al. Fam Cancer 2024
• Cancer risks among first-degree relatives of women with a genetic predisposition to breast cancer.
  Qingyang Xiao et al. J Natl Cancer Inst 2024
• Modeling health outcomes associated with BRCA testing and treatment strategies for patients with metastatic pancreatic cancer.
  Neeharika Agnihotri et al. Pancreatology 2024
• Prospective observational study on biomarkers of response in pancreatic ductal adenocarcinoma
  L Jiang et al, Nature Medicine, January 29, 2024
• From Machine Learning to Patient Outcomes: A Comprehensive Review of AI in Pancreatic Cancer.
  Satvik Tripathi et al. Diagnostics (Basel) 2024 14(2)
• The Utility of Artificial Intelligence in the Diagnosis and Management of Pancreatic Cancer.
  Vikash Kumar et al. Cureus 2023 15(11) e49560
• Air quality and cancer risk in the All of Us Research Program.
  Andrew Craver et al. Cancer Causes Control 2023
• TransformEHR: transformer-based encoder-decoder generative model to enhance prediction of disease outcomes using electronic health records.
  Zhichao Yang et al. Nat Commun 2023 14(1) 7857
• Long or short? Telomere length and pancreatic cancer and its precursor lesions, a narrative review.
  Daniele Campa et al. Mutagenesis 2023
• Rate of Pathogenic Germline Variants in Patients With Lung Cancer.
  Steven Sorscher et al. JCO Precis Oncol 2023 7e2300190
• Large-scale pancreatic cancer detection via non-contrast CT and deep learning.
  Kai Cao et al. Nat Med 2023
• Real-Time Identification of Pancreatic Cancer Cases Using Artificial Intelligence Developed on Danish Nationwide Registry Data.
  Anders Bo Bojesen et al. JCO Clin Cancer Inform 2023 7e2300084
• Do polygenic risk scores add to clinical data in predicting pancreatic cancer? a scoping review.
  Louise Wang et al. Cancer Epidemiol Biomarkers Prev 2023 8
• A review of deep learning and radiomics approaches for pancreatic cancer diagnosis from medical imaging.
  Lanhong Yao et al. Curr Opin Gastroenterol 2023
• Oncogenic drivers and therapeutic vulnerabilities in KRAS wild-type pancreatic cancer.
  Harshabad Singh et al. Clin Cancer Res 2023
• Machine learning-based prediction of surgical benefit in borderline resectable and locally advanced pancreatic cancer.
  Leiming Zhang et al. J Cancer Res Clin Oncol 2023
• Genetic counselling referral practices for patients with pancreatic adenocarcinoma: A French retrospective multicentre observational cohort study (CAPANCOGEN).
  Mathias Brugel et al. Pancreatology 2023
• Reliability of Medical Information Provided by ChatGPT: Assessment Against Clinical Guidelines and Patient Information Quality Instrument.
  Harriet Louise Walker et al. J Med Internet Res 2023 25e47479
• Feasibility of the Genetic Information Assistant Chatbot to Provide Genetic Education and Study Genetic Test Adoption Among Pancreatic Cancer Patients at Johns Hopkins Hospital.
  Nidhi Soley et al. AMIA Jt Summits Transl Sci Proc 2023 2023497-504
• Precision medicine meets cancer vaccines.
  et al. Nat Med 2023 6
• Diverse genetic spectrum among patients who met the criteria of hereditary breast, ovarian and pancreatic cancer syndrome.
  Po-Han Lin et al. J Gynecol Oncol 2023
• Pancreatic Cancer Screening for At-risk Individuals (Pancreas Scan Study): Yield, Harms and Outcomes from a Prospective Multi-Center Study.
  Ishani Shah et al. Am J Gastroenterol 2023
• Smaller panel, similar results: genomic profiling and molecularly informed therapy in pancreatic cancer.
  T M Reissig et al. ESMO Open 2023 8(3) 101539
• A deep learning algorithm to predict risk of pancreatic cancer from disease trajectories.
  Davide Placido et al. Nat Med 2023 5
• Familial aggregation of early-onset cancers in early-onset breast cancer families.
  Jasmiina N J Rantala et al. Int J Cancer
• Patients with deleterious germline mutations: A heterogeneous population for pancreatic cancer screening?
  Alexandra M Roch et al. J Surg Oncol
• Prevalence of a BRCA2 Pathogenic Variant in Hereditary-Breast-and-Ovarian-Cancer-Syndrome Families with Increased Risk of Pancreatic Cancer in a Restricted Italian Area.
  Valentina Zampiga et al. Cancers (Basel) 2023 15(7)
• Prevalence and Risk Factors of Germline Pathogenic Variants in Pancreatic Ductal Adenocarcinoma.
  Kum Hei Ryu et al. Cancer research and treatment 2023
• IPMN-LEARN: A linear support vector machine learning model for predicting low-grade intraductal papillary mucinous neoplasms.
  Yasmin Genevieve Hernandez-Barco et al. Annals of hepato-biliary-pancreatic surgery 2023
• Prevalence of Germline Mutations in Cancer Predisposition Genes in Patients with Pancreatic Cancer or Suspected Related Hereditary Syndromes: Historical Prospective Analysis.
  Arianna Dal Buono et al. Cancers 2023 15(6)
• The Landscape and Therapeutic Targeting of BRCA1, BRCA2 and Other DNA Damage Response Genes in Pancreatic Cancer.
  Ioannis A Voutsadakis et al. Current issues in molecular biology 2023 45(3) 2105-2120
• Artificial Intelligence for the Prediction and Early Diagnosis of Pancreatic Cancer: Scoping Review.
  Zainab Jan et al. Journal of medical Internet research 2023 25e44248
• A Double Whammy on Gastric Cancer Risk.
  Anne Müller et al. The New England journal of medicine 2023 3 (13) 1225-1229
• Adherence to NCCN Genetic Testing Guidelines in Pancreatic Cancer and Impact on Treatment.
  Fionnuala Crowley et al. The oncologist 2023
• Assessment of a Peer Physician Coaching Partnership Between a Designated Cancer Center Genetics Service and a Community Cancer Network Hospital.
  Lauren G Santos et al. JAMA network open 2023 6(3) e231723
• Rare germline variants in pancreatic cancer and multiple primary cancers: an autopsy study.
  Hiroo Fujitani et al. European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 2023
• Precision Oncology in Pancreatic Cancer: Experiences and Challenges of the CCCMunich Molecular Tumor Board.
  Klara Dorman et al. Targeted oncology 2023
• Identification of individuals at high-risk for pancreatic cancer using a digital patient-input tool combining family cancer history screening and new-onset diabetes.
  Derk C F Klatte et al. Preventive medicine reports 2023 31102110
• Review of genetic and pharmacogenetic differences in cytotoxic and targeted therapies for pancreatic cancer in African Americans.
  Guettchina Telisnor et al. Journal of the National Medical Association 2023
• The Michigan Genetic Hereditary Testing (MiGHT) study's innovative approaches to promote uptake of clinical genetic testing among cancer patients: a study protocol for a 3-arm randomized controlled trial.
  Lynette Hammond Gerido et al. Trials 2023 24(1) 105
• Utility of Comprehensive Genomic Profiling Tests for Patients with Incurable Pancreatic Cancer in Clinical Practice.
  Takuo Yamai et al. Cancers 2023 15(3)
• Characteristics of familial pancreatic cancer families with additional colorectal carcinoma.
  Bettina Lehman et al. Familial cancer 2023
• Evaluation of inherited germline mutations in cancer susceptibility genes among pancreatic cancer patients: a single-center study.
  Francesca Tavano et al. Molecular medicine (Cambridge, Mass.) 2023 29(1) 14
• Artificial intelligence in pancreatic cancer: diagnosis, limitations, and the future prospects-a narrative review.
  Maanya Rajasree Katta et al. Journal of cancer research and clinical oncology 2023
• Evaluation of deep learning based implanted fiducial markers tracking in pancreatic cancer patients.
  Abdella M Ahmed et al. Biomedical physics & engineering express 2023
• FAMILIAL PANCREATIC CANCER.
  Nero Lorenzo Del et al. Clinics and research in hepatology and gastroenterology 2023 102079
• Sotorasib in KRAS p.G12C–Mutated Advanced Pancreatic Cancer
  JH Stickler et al, NEJM, December 21, 2022
• Pancreatic Cancer: Beyond Brca Mutations
  V Ricci et al, J Per Med, December 16, 2022
• Pancreatic Tumorigenesis: Precursors, Genetic Risk Factors and Screening.
  Badheeb Mohamed et al. Current oncology (Toronto, Ont.) 2022 29(11) 8693-8719

More